Find more information on the neutralizing activity of our antibodies for the corresponding AAV serotypes below.
Find more information on the neutralizing activity of the ADK1a (Cat. No. 610150) antibody in the following publication:
The A20 antibody (Cat. No. 61055) was tested for neutralization using different antibody concentrations. After the HeLa cells were seeded in a 96-well plate they were incubated for 48h with theAAV2 particles containing a GFP reporter and the indicated concentration of the A20 antibody.
The microscopic analysis of the cells clearly demonstrates the neutralizing activity of the A20 antibody by decreasing GFP expression with increasing antibody concentration.
Find more information on the neutralizing activity of the A20 antibody in the following publications:
The A20R antibody (Cat. No. 610298S) was tested for neutralization using different antibody concentrations. After the HeLa cells were seeded in a 96-well plate they were incubated for 48h with theAAV2 particles containing a GFP reporter and the indicated concentration of the A20R antibody.
The microscopic analysis of the cells clearly demonstrates the neutralizing activity of the A20R antibody by decreasing GFP expression with increasing antibody concentration.
The ADK5a antibody (Cat. No. 610148) was tested for neutralization using different antibody concentrations. After the HeLa cells were seeded in a 96-well plate they were incubated for 48h with theAAV5 particles containing a GFP reporter and the indicated concentration of the ADK5a antibody.
The microscopic analysis of the cells clearly demonstrates the neutralizing activity of the ADK5a antibody by decreasing GFP expression with increasing antibody concentration.
The ADK5b antibody (Cat. No. 610149) was tested for neutralization using different antibody concentrations. After the HeLa cells were seeded in a 96-well plate they were incubated for 48h with theAAV5 particles containing a GFP reporter and the indicated concentration of the ADK5b antibody.
The microscopic analysis of the cells clearly demonstrates the neutralizing activity of the ADK5b antibody by decreasing GFP expression with increasing antibody concentration.
Find more information on the neutralizing activity of the ADK5b antibody in the following publication:
The ADK6 antibody (Cat. No. 610159) was tested for neutralization using different antibody concentrations. After the HeLa cells were seeded in a 96-well plate they were incubated for 48h with theAAV6 particles containing a GFP reporter and the indicated concentration of the ADK6 antibody.
The microscopic analysis of the cells clearly demonstrates the neutralizing activity of the ADK6 antibody by decreasing GFP expression with increasing antibody concentration.
Find more information on the neutralizing activity of the ADK6 antibody in the following publication:
The ADK8 antibody (Cat. No. 610160) was tested for neutralization using different antibody concentrations. After the HeLa cells were seeded in a 96-well plate they were incubated for 48h with theAAV8 particles containing a GFP reporter and the indicated concentration of the ADK8 antibody.
The microscopic analysis of the cells clearly demonstrates the neutralizing activity of the ADK8 antibody by decreasing GFP expression with increasing antibody concentration.
Find more information on the neutralizing activity of the ADK8 antibody in the following publications:
The ADK9 antibody (Cat. No. 690162) was tested for neutralization using different antibody concentrations. After the HeLa cells were seeded in a 96-well plate they were incubated for 48h with theAAV9 particles containing a GFP reporter and the indicated concentration of the ADK9 antibody.
The microscopic analysis of the cells clearly demonstrates the neutralizing activity of the ADK9 antibody by decreasing GFP expression with increasing antibody concentration.
Find more information on the neutralizing activity of the ADK9 antibody in the following publications:
The ADK9-1R antibody (Cat. No. 610178) was tested for neutralization using different antibody concentrations. After the HeLa cells were seeded in a 96-well plate they were incubated for 48h with theAAV9 particles containing a GFP reporter and the indicated concentration of the ADK9-1R antibody.
The microscopic analysis of the cells clearly demonstrates the neutralizing activity of the ADK9-1R antibody by decreasing GFP expression with increasing antibody concentration.